Almost 90% slash in prices of nine anti-cancer drugs

National Pharmaceutical Pricing Authority (NPPA) has slashed the prices of 9 non-scheduled cancer drugs by up to 87%.Earlier,in February this year,the government had capped 42 cancer drugs at 30 %. NPPA is an independent body set up in 1997 under Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers. Its mandate is to fix/revise controlled bulk… Continue reading Almost 90% slash in prices of nine anti-cancer drugs

Most anti-cancer drugs costly despite price cap, says AIDAN

According to All India Drug Action Network (AIDAN),despite the Government’s decision of price capping of 42 anti-cancer drugs most cancer medicines still remain unaffordable to most Indians because there is no curb on profiteering by pharma manufacturers.Profiteering means unfair profit realized by traders by manipulating prices,tax rate adjustment among others. They have said that the… Continue reading Most anti-cancer drugs costly despite price cap, says AIDAN

Plea in court against drug pricing regulator’s move to cap trade margin for cancer medicines

The National Pharmaceutical Pricing Authority (NPPA) decision to cap the maximum trade margin for cancer medicine has been challenged in the Karnataka High Court by a private hospital group. Earlier,National Pharmaceutical Pricing Authority (NPPA) had invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control by capping trade… Continue reading Plea in court against drug pricing regulator’s move to cap trade margin for cancer medicines

Prices slashed for 463 cancer drugs

The National Pharmaceutical Pricing Authority (NPPA) has invoked powers under Drugs (Prices Control) Order,2013 and brought 463 non-scheduled cancer medicines under price control.This will reduce the trage margin of the drug.The trade margin is the difference between the price at which the manufacturers sell to trade and the price that patients pay(maximum retail price). NPPA… Continue reading Prices slashed for 463 cancer drugs

Cancer drugs 87% cheaper after trade margin cap

Government has announced that maximum retail price(MRP) of 390 non-scheduled cancer medicines have been reduced by up to 87% Earlier,National Pharmaceutical Pricing Authority (NPPA) had invoked powers under Drugs (Prices Control) Order, 2013 and brought 42 non-scheduled anti-cancer drugs under price control by capping trade margin at 30%. The trade margin is the difference between… Continue reading Cancer drugs 87% cheaper after trade margin cap